Skip to content

Corporate brand

Unclaimed

IonSense is a Massachusetts-based analytical-technology company associated with direct analysis in real time mass spectrometry and DART ion-source systems.

Last updated August 31, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

IonSense is a Massachusetts-based analytical-technology company focused on direct analysis in real time, commonly abbreviated DART, and on related ambient mass-spectrometry equipment. Its principal technology enables the rapid examination of materials with limited sample preparation by ionizing samples in an open or near-ambient environment before analysis by a mass spectrometer. This approach is intended to support both qualitative identification and quantitative measurement across a range of scientific applications. The company’s technology is associated with the DART mass-spectrometry method, which can be used to analyze bioanalytical and medicinal materials, forensic samples, chemical-synthesis products, and other substances. In contrast with conventional workflows that may require extensive extraction, separation, or chromatographic preparation, ambient ionization can provide a faster screening or characterization step. The practical value of the system depends on the sample, the analytical method, and the mass spectrometer to which the ion source is connected. IonSense supplied DART ion sources designed to interface with mass-spectrometry platforms from several major manufacturers, including JEOL, Thermo Fisher Scientific, Bruker, Applied Biosystems, Agilent, and Waters. This compatibility-oriented role positioned IonSense as an instrumentation and enabling-technology supplier rather than as a consumer-facing brand. Its customers and users were primarily expected to be laboratories, research organizations, pharmaceutical and chemical developers, forensic practitioners, and other analytical-science users. IonSense was acquired by Bruker in April 2022. The transaction placed the IonSense technology and brand within a larger analytical-instrumentation group that already participates in mass spectrometry and related laboratory systems. The available reference material does not establish the transaction value, the identity of the company’s founder or executives, its precise founding year, or a separate current website. It also does not provide enough information to describe a broader consumer product portfolio, sales figures, geographic revenue split, or post-acquisition operating structure. Accordingly, IonSense is best characterized as a specialized scientific-instrumentation brand whose most identifiable offering is DART ion-source technology for ambient mass-spectrometric analysis.

History

IonSense developed in the field of ambient mass spectrometry, concentrating on direct analysis in real time technology. DART mass spectrometry is designed to allow materials to be analyzed rapidly, often with less sample preparation than is required by more conventional analytical workflows. The technique uses an ion source to generate ions from material presented to the source, after which a mass spectrometer measures the resulting signals. This makes the method useful for fast screening, identification, and, under suitable validated conditions, quantification. The company’s technology was directed toward several analytical domains. Reference material identifies bioanalysis, medicinal applications, forensic examination, and chemical-synthesis products among the relevant use cases. These areas share a need for rapid characterization of samples, whether for research, development, quality assessment, or investigative work. IonSense therefore occupied a specialist position in laboratory instrumentation and analytical workflow development rather than selling a broad range of general-purpose laboratory equipment. A notable aspect of IonSense’s business was the ability of its DART ion sources to interface with mass spectrometers made by multiple established vendors. Listed compatible manufacturers included JEOL, Thermo Fisher Scientific, Bruker, Applied Biosystems, Agilent, and Waters. Such interoperability could allow laboratories to add ambient-ionization capabilities to existing mass-spectrometry installations, although the available material does not specify individual model numbers, commercial terms, installation volumes, or the full technical range of the company’s products. IonSense was based in Massachusetts. Public reference material available for this entry does not establish a founding year, founder, detailed chronology of product releases, or a complete list of corporate officers. It does, however, record a significant ownership change: Bruker acquired IonSense in April 2022. The acquisition connected IonSense with a major analytical-instrumentation company that also operates in mass spectrometry. The available sources do not state whether the IonSense name continued as a standalone commercial brand, was integrated into Bruker’s product organization, or was maintained for particular DART products. The company’s documented history is consequently centered on the development and supply of DART ion-source technology and its eventual acquisition by Bruker. More detailed claims about early research, commercialization dates, product generations, customer adoption, financial performance, or post-acquisition management require additional reliable sources.

  • 2022

    Acquired by Bruker

    [1]

    Bruker acquired IonSense in April 2022, adding IonSense’s DART ion-source technology to its analytical-instrumentation activities.

Products and positioning

A specialized scientific-instrumentation supplier focused on rapid ambient-ionization analysis and compatibility with mass-spectrometry platforms from multiple manufacturers.

  • Ambient mass-spectrometry ion sources

    DART ion sources

    IonSense’s central offering was the DART ion source, an ambient-ionization component used to support direct analysis in real time mass spectrometry. The source is intended to enable rapid qualitative and quantitative examination of materials, including bioanalytical, medicinal, forensic, and chemical-synthesis samples. IonSense supplied sources that could be interfaced with mass-spectrometry systems from several major instrument manufacturers.

Brand decisions

  • 2022

    Sale to BrukerM&A

    Background

    IonSense operated as a specialist supplier of DART ion sources and related ambient mass-spectrometry technology.

    Action taken

    Bruker acquired IonSense in April 2022.

    Aftermath

    IonSense became part of Bruker’s analytical-instrumentation group. The available source does not specify the purchase price, integration structure, or subsequent brand strategy.

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/ionsense · Editorial policy · How profiles are compiled